(2-OXO-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 1g

1-Methyl-3-phenyl-1H-1,2,4-triazole-5-carbaldehyde, 97%, 250mg

2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione, 95.0%, 25mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,53 mm, Filmd. 2,00 µm, 1 Stück

2-ethoxy-4-formylphenyl acetate, 97.0%, 5g

3-(4-Bromo-1H-pyrazol-1-yl)benzonitrile, 95.0%, 1g

(5E)-5-(4-isopropylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

D(+)-Maltose-Monohydrat, 250 g

2,4-Bis(trifluoromethyl)-DL-phenylalanine, 5g

N-Acetyl-L-carnosine, 97.0%, 250mg

3-BROMO-4-PHENYLPYRIDINE, 95.0%, 1g

2,2,2-trifluoro-N-(pyridin-2-ylmethyl)acetamide, 95.0%, 1g

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g